Vicente V, Alberca I, Gonzalez R, Alegre A
Am J Hematol. 1987 Jan;24(1):107-9. doi: 10.1002/ajh.2830240114.
A patient who had developed a VIII:C IgG-Kappa antibody after her first delivery became pregnant for a second time. At that time the titer of the inhibitor had increased fourfold, remaining at high levels throughout the rest of the pregnancy. The neonate exhibited an inhibitor with characteristics identical to that of the mother which could not be detected 3 months after birth. No hemorrhagic complications in either of the subjects were observed.
一名患者在首次分娩后产生了VIII:C IgG-Kappa抗体，第二次怀孕。当时，抑制剂的滴度增加了四倍，在整个孕期的其余时间都维持在高水平。新生儿表现出与母亲相同特征的抑制剂，出生3个月后无法检测到。两名受试者均未观察到出血并发症。
